XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
RSUs
Common Shares
RSUs
Additional Paid-in Capital
Common Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2023     $ 222,205 $ 20,808 $ 5,565 $ (217,354) $ 31,224
Balance at beginning (In shares) at Dec. 31, 2023     21,370,565        
Net loss for the period           (6,585) (6,585)
Cumulative translation adjustment - net of tax of $nil         (969)   (969)
Shares issued in public offering and private placement     $ 21,079       21,079
Shares issued in public offering and private placement (in shares)     3,058,334        
Share-based compensation (note 10)       767     767
Balance at ending at Mar. 31, 2024     $ 243,284 21,575 4,596 (223,939) 45,516
Balance at ending (in shares) at Mar. 31, 2024     24,428,899        
Balance at beginning at Dec. 31, 2023     $ 222,205 20,808 5,565 (217,354) 31,224
Balance at beginning (In shares) at Dec. 31, 2023     21,370,565        
Net loss for the period             (13,504)
Cumulative translation adjustment - net of tax of $nil             (1,439)
Balance at ending at Jun. 30, 2024     $ 243,698 21,929 4,126 (230,858) 38,895
Balance at ending (in shares) at Jun. 30, 2024     24,481,835        
Balance at beginning at Mar. 31, 2024     $ 243,284 21,575 4,596 (223,939) 45,516
Balance at beginning (In shares) at Mar. 31, 2024     24,428,899        
Net loss for the period           (6,919) (6,919)
Cumulative translation adjustment - net of tax of $nil         (470)   (470)
Exercise of share options (note 10)     $ 1 (1)      
Exercise of share options (note 10) (in shares)     101        
Vesting of share-based payment award, equity instruments other than options (note10) $ 413 $ (413)          
Vesting of share-based payment award, equity instruments other than options (note 10) (in shares) 52,835            
Share-based compensation (note 10)       768     768
Balance at ending at Jun. 30, 2024     $ 243,698 21,929 4,126 (230,858) 38,895
Balance at ending (in shares) at Jun. 30, 2024     24,481,835        
Balance at beginning at Dec. 31, 2024     $ 281,552 21,298 2,742 (245,170) $ 60,422
Balance at beginning (In shares) at Dec. 31, 2024     30,039,809       30,039,809
Net loss for the period           (10,724) $ (10,724)
Cumulative translation adjustment - net of tax of $nil         103   103
Vesting of share-based payment award, equity instruments other than options (note10) $ 89 $ (89)          
Vesting of share-based payment award, equity instruments other than options (note 10) (in shares) 13,333            
Share-based compensation (note 10)       989     989
Balance at ending at Mar. 31, 2025     $ 281,641 22,198 2,845 (255,894) 50,790
Balance at ending (in shares) at Mar. 31, 2025     30,053,142        
Balance at beginning at Dec. 31, 2024     $ 281,552 21,298 2,742 (245,170) $ 60,422
Balance at beginning (In shares) at Dec. 31, 2024     30,039,809       30,039,809
Net loss for the period             $ (26,419)
Cumulative translation adjustment - net of tax of $nil             2,816
Balance at ending at Jun. 30, 2025     $ 281,641 23,649 5,558 (271,589) $ 39,259
Balance at ending (in shares) at Jun. 30, 2025     30,053,142       30,053,142
Balance at beginning at Mar. 31, 2025     $ 281,641 22,198 2,845 (255,894) $ 50,790
Balance at beginning (In shares) at Mar. 31, 2025     30,053,142        
Net loss for the period           (15,695) (15,695)
Cumulative translation adjustment - net of tax of $nil         2,713   2,713
Share-based compensation (note 10)       1,451     1,451
Balance at ending at Jun. 30, 2025     $ 281,641 $ 23,649 $ 5,558 $ (271,589) $ 39,259
Balance at ending (in shares) at Jun. 30, 2025     30,053,142       30,053,142